Aflac Incorporated (AFL) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This summary covers Aflac Incorporated's unaudited financial results for the quarter and nine months ended September 30, 2024. Aflac is a leading provider of supplemental health and life insurance, operating primarily in two segments: Aflac Japan and Aflac U.S. The company's results are significantly influenced by the Japanese yen/U.S. dollar exchange rate, as a substantial portion of its business is conducted in yen.
Key Financial Metrics
| Metric (in millions, except per share) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Total Revenues | $2,949 | $4,950 | $13,524 | $14,923 |
| Net Earnings | $(93) | $1,569 | $3,541 | $4,391 |
| Diluted EPS | $(0.17) | $2.64 | $6.23 | $7.28 |
| Net Investment Gains (Losses) | $(1,408) | $423 | $239 | $1,101 |
| Pretax Adjusted Earnings | $1,438 | $1,298 | $3,872 | $3,571 |
| Operating Cash Flow (9M) | $2,374 | $2,608 | - | - |
| Cash and Cash Equivalents | $5,612 | $4,306 | - | - |
| Total Assets | $128,442 | $126,724 | - | - |
| Total Liabilities | $103,612 | $104,739 | - | - |
| Shareholders' Equity | $24,830 | $21,985 | - | - |
Material Changes vs. Prior Period
- Net Earnings Volatility: Q3 2024 reported a net loss of $93 million compared to $1.57 billion in Q3 2023. This decline was primarily driven by a $1.4 billion net investment loss in Q3 2024, contrasting with a $423 million gain in the prior year. The investment loss included significant foreign exchange-related losses due to the yen strengthening by 12.9% during the quarter.
- Revenue Decline: Total revenues decreased 40% year-over-year in Q3 to $2.9 billion, largely due to the volatility in net investment gains/losses. Net earned premiums declined 4.3% to $3.3 billion.
- Segment Performance:
- Aflac Japan: Pretax adjusted earnings increased 23.5% to $1.07 billion, driven by a $50 billion yen reserve remeasurement gain from assumption updates and lower benefits. However, net earned premiums decreased due to reinsurance activity and limited-pay products reaching paid-up status.
- Aflac U.S.: Pretax adjusted earnings decreased 26.8% to $350 million, primarily due to a decrease in reserve remeasurement gains and higher incurred claims, partially offset by growth in net earned premiums.
- Investment Portfolio: The company recognized $141 million in credit loss allowances in Q3. The portfolio includes significant exposure to transitional real estate loans (TREs), with $525 million in loans 90 days or more past due as of September 30, 2024.
Guidance, Outlook, and Risks
- Foreign Exchange Risk: The company highlights significant exposure to yen/dollar fluctuations. A strengthening yen increases reported earnings but creates translation losses on U.S. dollar-denominated assets held by Aflac Japan. Management utilizes hedging strategies to mitigate this, though costs fluctuate.
- Interest Rate and Credit Risk: The company monitors credit quality indicators for its loan portfolio, particularly in the commercial real estate sector. While the portfolio is diversified, there is exposure to office properties which have been affected by market conditions.
- Regulatory Environment: Aflac Japan is subject to the Solvency Margin Ratio (SMR) and will transition to an economic value-based solvency regime (ICS) in 2025. Aflac U.S. remains compliant with Risk-Based Capital (RBC) requirements.
- Capital Allocation: The company continues its share repurchase program, having repurchased $2.1 billion (23.4 million shares) in the first nine months of 2024. The quarterly dividend was increased to $0.50 per share in Q3 2024.
- Subsequent Event: In October 2024, the company received approval for an internal reinsurance transaction where Aflac Japan will cede 30% of certain cancer insurance liabilities to Aflac Re, expected to transfer approximately ¥275 billion in reserves.
Investor Verification Checklist
- Investment Loss Drivers: Verify the specific composition of the $1.4 billion Q3 net investment loss, particularly the impact of foreign currency derivatives versus credit losses.
- Reserve Remeasurement: Assess the sustainability of the $50 billion yen reserve remeasurement gain in Aflac Japan, which significantly boosted adjusted earnings but may not recur at the same magnitude.
- Commercial Real Estate Exposure: Review the aging of transitional real estate loans (TREs) and the adequacy of the allowance for credit losses given the $525 million in loans 90+ days past due.
- Yen Hedging Costs: Monitor the trend in amortized hedge costs/income, as fluctuations in interest rate differentials between the U.S. and Japan directly impact adjusted earnings.
- Reinsurance Impact: Evaluate the long-term effect of the internal reinsurance transaction with Aflac Re on Aflac Japan's capital position and reported premiums.